Anatomy of Joint Pain
CLINICAL
EXCELLENCE
Craig F. Buhler
References:
1. Gabriel SE, Febring RA: Trends in the utilization of nonsteroidal anti-inflammatory drugs in the United States, 1986-1990. J Clin Epidemiol45: 1041-1044, 1992
2. Anti-arthritic medication usage: 1991. Stat Bull 73:2534, 1992
3. Frost and Sullivan Market Intelligence: U.S. Autoimmune Disease Therapeutic Product Markets (January 1995). Report No. 5222-52. Mountain View, CA, Frost ana Sullivan, 1995
4. Frost and Sullivan Market Intelligence: Pain Management Markets (August 1993). Report No. 894-52. Mountain View, CA, Frost and Sullivan, 1995
5. TomitaDK, Baum C, Kennedy DL: Drug Utilization in the United States-1987, Ninth Annual Review. (DHHS publication no. PB91-198838). Washington, DC, Department of Health and Human Services, 1988
6. TomitaDK, Kennedy DL, Baum C: Drug Utilization in the United States-1988, Tenth Annual Review. (DHHS publication no. PB90-15921). Washington, DC, Department of Health and Human Services, 1988
7. Burke LB, Baum C, Jolson HM: Drug Utilization in the United States-1989, Eleventh Annual Review. (DHHS publication no. PB91-1938838). Washington, DC, Department of Health and Human Services, 1991
8. Gibson TNonsteroidal anti-inflammatory drugs-another look. Br J Rheumatol 2 7:87-90,1988
9. Guess HA, West R, Strand IM, Helston D, Lydick EG, Bergman U, Wolski K: Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 41:35-45, 1988
10. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF: Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 29:706-714,1986
11. Wilcox CM, Allison J, BenzulyD, BorumM, CryerB, Grosser T, HuntR Ladabaum U, Lanas A, PaulusH, Regueiro C, Sandler RS, Simon L. Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme, Inhibitors and Aspirin. Clinical Gastroenterology and Hepatology. September 2006;4(9): 1082-9.
12. Cryer B andSpechler S. Peptic Ulcer Disease. In: FeldmanM, SVeisengerMandFordtranJS, eas. Gastrointestinal and Liver Disease, 8th ed. Philadelphia, WB Saunders Company. 2006
13. Sherine E. Gabriel and Judith L. Wagner, Cost and Effectiveness of Nonsteroidal AntiInflammatory Drugs: The Importance of Reducing Side Effects.. Arth Care and Res. Vol. 10,No.l Feb 1997
14. Monica L. Wolford, M.A.; Kathleen Palso, M.A.; and Anita Bercovitz, M.P.H., Ph.D., Hospitalization for Total Hip Replacement Among Inpatients Aged 45 and Over: United States, 2000-2010; NCHS Data Brief No. 186, February 2015
15. Sonja N. Williams, M.P.H.; Monica L. Wolford, M.A.; and Anita Bercovitz, M.P.H., Ph.D. Hospitalization for Total Knee Replacement Among Inpatients Aged 45 and Over: United States, 2000-2010 NCHS Data Brief No. 210 September 2015
16. Alfredson H, Forsgren S, Thor sen A, Fahlstrom M, Johansson H, Lorentzon R. Glutamate NMDAR1 receptors localised to nerves in human Achilles tendons. Implications for treatment? Knee Stirg Sports Traumatol Arthrosc. 2001;9:123-6.
17. Alfredson H, Thorsen K, Lorentzon R. In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg Sports Traumatol Arthrosc. 1999; 7:3 78-81.
18. Khan KM, Cook JL, Kannus P, Mafjdli N, Bonar SF. Time to abandon the “tendinitis ” myth. BMJ. 2002;324:626-7. Cook JL, Feller JA, Bonar SF, Khan KM. Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes ’patellar tendons. J Orthop Res. 2004;22:334-8.
19. H. Van der Worp, H. J. de Poel, R. L. Diercks, I. van den Akker-Scheek, J. ZwerverJ umper’s Knee or Lander ,’v Knee? A Systematic Review of the Relation between Jump Biomechanics and Patellar Tendinopathy. Int J Sports Med, DOI: 10.1055/s-0033-1358674 Review, © Georg Thieme Verlag KG Stuttgart • New York
20. CookJL, Khan KM, Harcourt PR et al: A cross sectional study of 100 athletes withfumper ,’v knee managed conservatively and surgically. Br J Sports Med 31: 332-336, 199/
21. Kettunen JA, Kujala UM, Kaprio J, et al: Lower-limb function among former elite male athletes. Am J Sports Med 29: 2-8, 2001
22. Jyrki A. Kettunen, *† PhD, Martti Kvistfr MD, Erkki Alanen,§ PhD, and Urho M. Kujala, MD Long-Term Prognosis for Jumper s Knee in Male Athletes A Prospective Follow-up Study; The American Journal of Sports Medicine, Vol. 30, No. 5
23. Kendall & Kendall,
24. Goodheart, Applied Kinesiology 1964
25. Beardall. Clinical Kinesiology 1976
26. Benjamin, H. Toumi, J.R Ralphs, G. Bydder, T.M. Best, & S. Milz, Where tendons and ligaments meet bone: attachment sites (‘entheses ’) in relation to exercise and/or mechanical load; April 18 2006; Journal of Anatomy.
27. Pleotz 1938, Rummer 1959, 1962, 1978 and Pauwel 1980.
28. Palsey PD. Tendon and ligament insertions—a possible source of musculoskeletal pain. Cranio 1997 Jul; 15(3): 194-202.
29. Buhler, C.F.
30. David Andrew Rice, Peter John McNair, Quadriceps Arthrogenic Muscle Inhibition: Neural Mechanisms and Treatment Perspectives; Seminars in Arthritis & Rheumatism, Dec. 2010, Vol. 40, Issue 3, P 250-266
31. Hopkins, J T; Ingersoll, C D Arthrogenic muscle response to a simulated ankle joint effusion, Br J Sports Med 2004;38:26-30 doi: 10.1136 bjsm. 2002
32. Hopkins, J T; Ingersoll, C D. 2000
33. R M Palmieri, C D Ingersoll, MA Hoffman, ML Cordova, D A Porter, JE Edwards, JP Babington, BA Krause, MB Stone; Arthrogenic muscle response to a simulated ankle joint effusion, Br J Sports Med 2004;38:26-30
34. Young A. 1993
35. Knese & Biermann 1958
